ZETA|Newsroom|The Critical Role of Predictive Bioreactor Characterization in Process-based Upscaling
From to ZETA
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
White Paper

The Critical Role of Predictive Bioreactor Characterization in Process-based Upscaling

ZETA highlights the critical role of predictive bioreactor characterization in pharmaceutical upscaling, ensuring consistent product quality and yield across scales. By accurately replicating lab-scale conditions in large-scale bioreactors, manufacturers can streamline validation and meet regulatory requirements more efficiently.
Technical TextProcess ExpertiseProducts
Mobile pilot-scale glass bioreactor system

New scaling strategies are developed

Bioreactor characterization plays a central role in process-based upscaling. New scaling strategies are developed based on standard scaling procedures and a growing database of measured process parameters.

Bioreactors used for industrial upstream processing

In bioreactors, microorganisms or cell cultures produce complex therapeutic proteins and other biopharmaceuticals. To achieve the optimum conditions, the design of the bioreactor and a sophisticated selection of parameters within the fermentation process is crucial. The goal in the design of the bioreactors used for industrial upstream processing is to maintain similar process conditions to those which apply on a small scale during product development and validation.

This raises the question:

“To what extent is the replication of the environmental conditions of a small-scale lab reactor applicable to that of a large-scale bioreactor of 20,000 liters or more?”

Thorough bioreactor characterization leads to insights beneficial for scaling and makes it easier to prove regulatory requirements.

Florian Krainer
Portfolio Manager
Portrait picture of a person wearing a white shirt and a black blazer in front of a light background.
I would like to receive regular information and electronic advertising and agree that my data may be processed and used for this purpose by all companies of the ZETA Group worldwide.
zeta.com is committed to protecting and respecting your privacy, and we’ll only use your personal information to administer your account and to provide the products and services you requested from us. By submitting, I agree to the Terms of Use and the Privacy Policy.
>

Download white paper predictive bioreactor characterization

Predictive bioreactor characterization is key to successful pharmaceutical upscaling, ensuring consistent quality and yield. It enables lab-scale conditions to be accurately replicated at production scale, streamlining validation and compliance.

Please complete the form to receive the requested content.

zeta.com is committed to protecting and respecting your privacy, and we’ll only use your personal information to administer your account and to provide the products and services you requested from us. By submitting, I agree to the Terms of Use and the Privacy Policy.

Show content